310 results on '"Zelniker, Thomas A."'
Search Results
2. ANGPTL3 inhibition, dyslipidemia, and cardiovascular diseases
3. Effect of monovalent COVID-19 vaccines on viral interference between SARS-CoV-2 and several DNA viruses in patients with long-COVID syndrome
4. Smart Data Logger with Continuous ECG Signal Monitoring
5. Effects of dapagliflozin on hospitalisations in people with type 2 diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial
6. Positionspapier Herzinsuffizienz und Diabetes
7. A Novel Approach to Continuous Heart Rhythm Monitoring for Arrhythmia Detection
8. Biomarker Prediction of Complex Coronary Revascularization Procedures in the FOURIER Trial
9. Abstract 14870: Adrenomedullin in Patients With Out-of-Hospital Cardiac Arrest
10. Abstract 13069: Left Atrial Mechanics in Patients With Hypertrophic Cardiomyopathy
11. A Novel Approach to Continuous Heart Rhythm Monitoring for Arrhythmia Detection
12. Effect of Evolocumab on Complex Coronary Disease Requiring Revascularization
13. Soluble ST2 in Heart Failure: A Clinical Role beyond B-Type Natriuretic Peptide
14. Editorial: Exploring modern approaches to address critical care challenges in risk stratification for cardiology
15. Relationship between markers of inflammation and hemodynamic stress and death in patients with out-of-hospital cardiac arrest
16. Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial
17. Cardiac and Renal Effects of Sodium-Glucose Co-Transporter 2 Inhibitors in Diabetes: JACC State-of-the-Art Review
18. Interruption of vascular endothelial growth factor receptor 2 signaling induces a proliferative pulmonary vasculopathy and pulmonary hypertension
19. Early versus delayed coronary angiography in patients with out-of-hospital cardiac arrest and no ST-segment elevation: a systematic review and meta-analysis of randomized controlled trials
20. A novel prediction model for pulmonary embolism: from dichotomizing algorithms to personalized likelihood
21. Association of Cardiac Biomarkers With Major Adverse Cardiovascular Events in High-risk Patients With Diabetes
22. Abstract 16688: Effects of Evolocumab in Patients With Prior Percutaneous Coronary Intervention: An Analysis From the Fourier Trial
23. Abstract 15701: Relationship Between Cardiac Biomarkers and Major Adverse Cardiovascular Events in DECLARE-TIMI 58
24. Abstract 14770: Reduction With Evolocumab in Complex Coronary Disease Requiring Revascularization: Insights From the FOURIER Trial
25. Prognostic Value of High-Sensitivity Cardiac Troponin T Compared with Risk Scores in Stable Cardiovascular Disease
26. Response by Zelniker et al to Letter Regarding Article, “Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial”
27. Dapagliflozin and Cardiac, Kidney, and Limb Outcomes in Patients With and Without Peripheral Artery Disease in DECLARE-TIMI 58
28. Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial
29. The 6MWT as a prognostic tool in pulmonary arterial hypertension: results from the COMPERA registry
30. Interruption of viral interference by anti-SARS-CoV-2 vaccination
31. Mid-regional pro-adrenomedullin and lactate levels for risk stratification in patients with out-of-hospital cardiac arrest
32. Relationship of Fibroblast Growth Factor 23 With Hospitalization for Heart Failure and Cardiovascular Outcomes in Patients Undergoing Cardiac Surgery
33. ANGPTL3 inhibition, dyslipidemia, and cardiovascular diseases
34. Coronary Angiography after Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation:One-Year Outcomes of a Randomized Clinical Trial
35. Fibroblast growth factor 23 (FGF-23) is an early predictor of mortality in patients with cardiac arrest
36. Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus
37. Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction: Subanalysis From the DECLARE-TIMI 58 Trial
38. Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis of Cardiovascular Outcomes Trials
39. Coronary Angiography After Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation: One-Year Outcomes of a Randomized Clinical Trial.
40. Comparison of the prevalence of SARS-CoV-2 nucleoprotein antibodies in healthcare workers and an unselected adult and paediatric all-comer patient population: insights from a longitudinal study of healthcare workers and concurrent serial cross-sectional studies of patients at an academic medical centre in Austria
41. SGLT2 inhibitors in heart failure: insights from plasma proteomics
42. Association of Cardiac Biomarkers With Major Adverse Cardiovascular Events in High-risk Patients With Diabetes A Secondary Analysis of the DECLARE-TIMI 58 Trial
43. The prognostic value of right ventricular long axis strain in non-ischaemic dilated cardiomyopathies using standard cardiac magnetic resonance imaging
44. Long‐term mortality after acute coronary syndromes among patients with normal, mildly reduced, or reduced ejection fraction
45. Dapagliflozin and prevention of kidney disease among patients with type 2 diabetes– post hoc analyses from the DECLARE-TIMI 58 trial
46. Abstract 19116: Prognostic Performance of GDF-15 Across the Spectrum of Risk in Patients With NSTE-ACS Enrolled in MERLIN - TIMI 36
47. Abstract 17950: High-Dose Edoxaban Regimen versus Warfarin in Patients With Atrial Fibrillation and Established Coronary Artery Disease: Insights From the ENGAGE AF-TIMI 48 Trial
48. Efficacy of enteral ticagrelor in hypothermic patients after out-of-hospital cardiac arrest
49. Positionspapier Herzinsuffizienz und Diabetes
50. Relationship of diabetes, heart failure, and N‐terminal pro‐B‐type natriuretic peptide with cardiovascular outcomes in patients with atrial fibrillation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.